Quoin Pharmaceuticals Ltd. (QNRX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalILS (m); Additional Paid in CapitalUSD $85.27M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-582.00.
- 2026-03-31: Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalILS (m); Additional Paid in CapitalUSD $84.74M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-159.00.
- 2025-12-31: Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalILS (m); Additional Paid in CapitalUSD $84.09M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-613.00.
- 2025-09-30: Common Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalILS (m); Additional Paid in CapitalUSD $65.41M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
Quoin Pharmaceuticals Ltd. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital ILS | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) ILS | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Shares, Retired shares | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Common, Value USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Treasury Stock, Shares, Acquired shares | Retained Earnings ILS | Retained Earnings USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | (m) | $85.27M | $-582.00 | (m) | $-81.34M | $3.93M | (m) | 3 month · $532.95K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | (m) | $84.74M | $-159.00 | (m) | $-75.97M | $8.77M | (m) | 3 month · $444.52K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | (m) | $84.09M | $-613.00 | (m) | $-70.97M | $13.12M | (m) | 12 month · $1.15M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | (m) | $65.41M | (m) | (m) | $-66.62M | $-1.21M | (m) | 3 month · $182.19K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | (m) | $65.23M | $62.70M | (m) | $-62.67M | $2.55M | (m) | 3 month · $321.49K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | (m) | $64.90M | $59.00M | (m) | $-58.98M | $5.93M | (m) | 3 month · $360.36K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | (m) | $64.37M | $55.20M | (m) | $-55.17M | $9.20M | (m) | 12 month · $1.26M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | (m) | $58.30M | $-52.90M | (m) | $-52.85M | $5.44M | (m) | 3 month · $313.12K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | (m) | $57.98M | $50.50M | (m) | $-50.50M | $7.48M | (m) | 3 month · $313.12K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | (m) | $57.66M | $48.50M | (m) | $-48.53M | $9.13M | (m) | 3 month · $306.31K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | $51.87M | $46.20M | (m) | $-46.20M | $5.66M | (m) | 12 month · $1.09M | (m) | (m) | (m) | 12 month · 0.00 | (m) | (m) |
| 2023-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 45.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | (m) | $54.50M | $44.20M | (m) | $-44.15M | $7.41M | (m) | 3 month · $268.50K | $2.93M | (m) | (m) | 9 month · 45.00 | (m) | (m) |
| 2023-06-30 | $0.00 | (m) | $54.23M | $42.20M | (m) | $-42.23M | $9.07M | (m) | 3 month · $264.38K | $2.93M | (m) | (m) | 6 month · 2.64M | (m) | (m) |
| 2023-03-31 | $0.00 | (m) | $53.97M | $40.10M | (m) | $-40.12M | $10.91M | (m) | 3 month · $261.47K | $2.93M | (m) | (m) | 3 month · 2.64M | (m) | (m) |
| 2022-12-31 | $0.00 | (m) | $47.86M | $37.50M | (m) | $-37.52M | $7.41M | (m) | 12 month · $764.01K | $2.93M | (m) | 12 month · $296.36K | 12 month · 45.00 | (m) | (m) |
| 2022-09-30 | (m) | (m) | $47.62M | $35.50M | (m) | $-35.52M | $9.17M | (m) | 3 month · $267.28K | $2.93M | (m) | (m) | 2.64M | (m) | (m) |
| 2022-06-30 | $0.00 | (m) | $32.18M | $32.40M | (m) | $-32.42M | $-3.17M | (m) | 3 month · $229.44K | $2.93M | (m) | (m) | 2.64M | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-729.41K | (m) | (m) | (m) | (m) | 3 month · $296.36K | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | (m) | $31.66M | $28.10M | (m) | $-28.07M | $657.03K | (m) | (m) | $2.93M | 12 month · $1.90M | 12 month · $12.41M | 12 month · 2.64M 2.64M | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $-16.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | 128.79M | $-39.51M | $-14.85M | (m) | (m) | (m) | (m) | (m) | (m) | -128.79M | $-39.51M |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-10.51M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $100.00 | (m) | (m) | $-6.61M | $-6.61M | (m) | (m) | (m) | (m) | (m) | (m) | -118.94M | $-37.00M |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -112.22M | (m) |
| 2019-12-31 | (m) | 108.60M | $31.42M | (m) | (m) | (m) | $-4.51M | (m) | (m) | (m) | (m) | (m) | (m) | -100.86M | $-29.18M |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -89.97M | (m) |
| 2018-12-31 | (m) | 95.08M | (m) | (m) | (m) | (m) | $-2.95M | (m) | (m) | (m) | (m) | (m) | (m) | -84.06M | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -73.51M | $-20.14M |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -63.94M | $-18.44M |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -35.72M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |